Physician

Joseph S. Harawi, M.D.

According to 2025 Medicare claims, Joseph Harawi, M.D. (NPI: 1154465888) practices nephrology in the Grand Junction, CO market, with the plurality of this provider's patient population coming from Mesa, CO. This provider's primary affiliated billing organization is GRAND MESA NEPHROLOGY PLLC (NPI: 1154633220; TIN: 272850829) and primary practice location at 81506-3933. Harawi is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Harawi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 364 traditional Medicare patients, billed 1,495 HCPCS/CPT codes, and received $162,610 in Medicare payments. The top billing code was 90961 (Dialysis services, 2-3 physician visits per month (20 years or older)). Part D data shows 1,173 prescription claims across 216 beneficiaries totaling $89,577 in drug costs, led by Prosol (Parenteral Amino Acid 20% No.1). DME data shows 98 claims. Open Payments data shows 3 records totaling $73. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $205,043 and ending at $89,577. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	365	1,854	$196,401
2016	395	1,822	$187,957
2017	427	1,829	$181,793
2018	447	1,732	$189,840
2019	460	2,037	$232,817
2020	423	1,857	$224,087
2021	462	1,796	$235,962
2022	393	1,726	$191,893
2023	360	1,585	$178,022
2024	364	1,495	$162,610

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	190	1,882	$205,043
2016	175	1,268	$158,624
2017	159	977	$69,955
2018	170	1,168	$103,229
2019	175	1,013	$77,947
2020	171	1,295	$106,919
2021	185	1,100	$84,586
2022	196	1,194	$83,297
2023	210	1,260	$104,185
2024	216	1,173	$89,577

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	186	$11,174
2016	N/R	82	$3,613
2017	N/R	100	$11,031
2018	N/R	126	$14,301
2019	N/R	93	$29,632
2020	N/R	132	$7,858
2021	N/R	63	$4,518
2022	N/R	168	$7,432
2023	N/R	122	$6,870
2024	N/R	98	$7,586

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90961	Dialysis services, 2-3 physician visits per month (20 years or older)	35	132	$214
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	46	67	$135
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	144	283	$95
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	39	85	$59
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	161	225	$58

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prosol	Parenteral Amino Acid 20% No.1	67	460	$15,175
Eliquis	Apixaban	18	780	$15,076
Jardiance	Empagliflozin	15	750	$14,425
Sevelamer Carbonate	Sevelamer Carbonate	45	2,306	$7,180
Clinolipid	Fat Emulsion/Olive/Soy/Phospho	13	91	$3,190

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7503	Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg	N	N/R	14	$5,870
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	12	$554
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	28	$527
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	19	$334
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	25	$301

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$73	ANI Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Joseph S. Harawi, M.D.?

Tedicare shows public-source Medicare data for Joseph S. Harawi, M.D. (NPI 1154465888), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joseph S. Harawi, M.D. have ACO affiliation data?

Joseph S. Harawi, M.D. is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Joseph S. Harawi, M.D.?

Joseph S. Harawi, M.D. is linked to GRAND MESA NEPHROLOGY PLLC (billing NPI 1154633220) in the available physician profile data.

Does Joseph S. Harawi, M.D. have Open Payments data?

Joseph S. Harawi, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.